0
Obstructive Lung Diseases |

Clinical Outcomes in Chronic Obstructive Pulmonary Disease Are Associated With Perception of Dyspnea More Than Exacerbation Risk or Disease Severity Measured by Lung Function

Sandra Adams*, MD; Vincent Fan, MD; Huong Nguyen, PhD; Soo Borson, MD; Ruth Kohen, MD; Gustavo Matute-Bello, MD; Genevieve Pagalilauan, MD; Antonio Anzueto, MD
Author and Funding Information

UTHSCSA/STVHCS, San Antonio, TX


Chest. 2012;142(4_MeetingAbstracts):676A. doi:10.1378/chest.1389751
Text Size: A A A
Published online

Abstract

SESSION TYPE: COPD: Severity and Risk Predictors

PRESENTED ON: Monday, October 22, 2012 at 11:15 AM - 12:30 PM

PURPOSE: In December 2011, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Executive committee published revised recommendations for the classification and assessment of COPD patients. The new grading system is based on symptoms, exacerbations risk (AECOPD) within the last year, and lung function. The purpose of this study was to examine which factors from the new grading system were most closely associated with quality of life, functional status, and depression in COPD patients.

METHODS: Cross-sectional analysis from an ongoing longitudinal observational study of depression in COPD. Patients completed spirometry, Modified Medical Research Council (MRC) dyspnea scale, questions related to AECOPD within the last year, chronic respiratory questionnaire (CRQ), depression interview (Personal Health Questionnaire, PHQ-9), and six-minute walk test (6MWT) at study entry. We categorized participants into the 4 new GOLD categories (Grade A-D). We used Analysis of variance and Chi-squared tests for continuous and categorical variables, respectively.

RESULTS: A total of 158 COPD patients were included in the analysis (age: 66±9 years; 22% females; forced expiratory volume in 1 second (FEV1) %predicted of 41±16%; mean number of AECOPD within the last year = 1.03; MRC=2.0±-1.14. The percentage of patients in each grade was: A: 18%, B: 9%, C: 22%, D: 51%. The CRQ was significantly higher for Grades A and C (105±17.7 and 98±20, respectively) than for Grades B and D (80±19 and 84±22, respectively) (p<0.001). The 6MWT distance was also higher for Grades A and C than for Grades B and D (p<0.001). Although depression history was similar across all Grades (p=0.32), more Grades B and D patients had high depression scores (PHQ-9 ≥10) than those in Grades A and C (p=0.04).

CONCLUSIONS: In patients with COPD, perception of dyspnea was more associated with quality of life, functional status and depression than was disease severity based on spirometry and exacerbations risk.

CLINICAL IMPLICATIONS: Systematically assessing dyspnea in COPD patients is important since perception of dyspnea is a driving factor in clinical outcomes.

DISCLOSURE: Sandra Adams: Grant monies (from sources other than industry): Chest Foundation, NIH, VA Cooperative Studies Program, Grant monies (from industry related sources): Bayer, Boehringer Ingelheim, Centocor, GSK, Novartis, Pfizer, Schering Plough, Other: Honoraria for Speaking (Unrestricted Grants for Continuing Education): ABComm, Altana, AstraZeneca Pharmaceuticals LP; Aventis, Bayer Pharmaceuticals Corp; Boehringer Ingelheim Pharmaceuticals, Inc; GlaxoSmithKline; Novartis Pharmaceuticals AG; Nycomed, Pfizer Inc; Schering-Plough Corp

Vincent Fan: Grant monies (from sources other than industry): NIH, Veterans Administration, Consultant fee, speaker bureau, advisory committee, etc.: Uptake Medical

Huong Nguyen: Grant monies (from sources other than industry): NIH, CDC, VA

Soo Borson: Grant monies (from sources other than industry): NIH

Ruth Kohen: Grant monies (from sources other than industry): NIH

Gustavo Matute-Bello: Grant monies (from sources other than industry): NIH

Genevieve Pagalilauan: Other: Writes Practical Reviews of Internal Medicine for Oakstone Publishing

Antonio Anzueto: Grant monies (from sources other than industry): NIH, NHLBI, Grant monies (from industry related sources): GSK, Consultant fee, speaker bureau, advisory committee, etc.: GSK, BI, Forest, Dey, Other: Member of the GOLD Executive and scientific committee

No Product/Research Disclosure Information

UTHSCSA/STVHCS, San Antonio, TX

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543